Literature DB >> 13626287

Study of a new schizophrenomimetic drug; sernyl.

E D LUBY, B D COHEN, G ROSENBAUM, J S GOTTLIEB, R KELLEY.   

Abstract

Entities:  

Keywords:  ANESTHETICS; SCHIZOPHRENIA

Mesh：

Substances：

Year:  1959        PMID： 13626287     DOI： 10.1001/archneurpsyc.1959.02340150095011

Source DB:  PubMed          Journal:  AMA Arch Neurol Psychiatry        ISSN： 0096-6886


× No keyword cloud information.
  195 in total

1.  Effects of phencyclidine (PCP) and MK 801 on the EEGq in the prefrontal cortex of conscious rats; antagonism by clozapine, and antagonists of AMPA-, alpha(1)- and 5-HT(2A)-receptors.

Authors:  Claude Sebban; Brigitte Tesolin-Decros; Jorge Ciprian-Ollivier; Laurent Perret; Michael Spedding
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

Review 2.  Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease.

Authors:  Michel Cyr; Frederic Calon; Marc Morissette; Thérèse Di Paolo
Journal:  J Psychiatry Neurosci       Date:  2002-01       Impact factor: 6.186

3.  Hyperfunction of dopaminergic and serotonergic neuronal systems in mice lacking the NMDA receptor epsilon1 subunit.

Authors:  Y Miyamoto; K Yamada; Y Noda; H Mori; M Mishina; T Nabeshima
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167

4.  Severe cross-modal object recognition deficits in rats treated sub-chronically with NMDA receptor antagonists are reversed by systemic nicotine: implications for abnormal multisensory integration in schizophrenia.

Authors:  Derek L Jacklin; Amit Goel; Kyle J Clementino; Alexander W M Hall; John C Talpos; Boyer D Winters
Journal:  Neuropsychopharmacology       Date:  2012-06-06       Impact factor: 7.853

5.  The Behavioral and Pharmacological Actions of NMDA Receptor Antagonism are Conserved in Zebrafish Larvae.

Authors:  John Chen; Roshni Patel; Theodore C Friedman; Kevin S Jones
Journal:  Int J Comp Psychol       Date:  2010

Review 6.  Cognitive dysfunction in schizophrenia: unifying basic research and clinical aspects.

Authors:  R W McCarley; M A Niznikiewicz; D F Salisbury; P G Nestor; B F O'Donnell; Y Hirayasu; H Grunze; R W Greene; M E Shenton
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1999       Impact factor: 5.270

Review 7.  NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development.

Authors:  John H Krystal; D Cyril D'Souza; Daniel Mathalon; Edward Perry; Aysenil Belger; Ralph Hoffman
Journal:  Psychopharmacology (Berl)       Date:  2003-09-02       Impact factor: 4.530

Review 8.  Glutamate receptor ion channels: structure, regulation, and function.

Authors:  Stephen F Traynelis; Lonnie P Wollmuth; Chris J McBain; Frank S Menniti; Katie M Vance; Kevin K Ogden; Kasper B Hansen; Hongjie Yuan; Scott J Myers; Ray Dingledine
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

Review 9.  Defects in Bioenergetic Coupling in Schizophrenia.

Authors:  Courtney R Sullivan; Sinead M O'Donovan; Robert E McCullumsmith; Amy Ramsey
Journal:  Biol Psychiatry       Date:  2017-10-24       Impact factor: 13.382

10.  Serotonergic/glutamatergic interactions: the effects of mGlu2/3 receptor ligands in rats trained with LSD and PCP as discriminative stimuli.

Authors:  J C Winter; J R Eckler; R A Rabin
Journal:  Psychopharmacology (Berl)       Date:  2003-11-04       Impact factor: 4.530
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.